1. O8 Gemcitabine induces pro-apoptotic BH3 only proteins and sensitizes pancreatic ductal adenocarcinoma cells for RLH-triggered immunogenic cell death. (1st October 2020) Authors: Metzger, P; Bourhis, HT; Stieg, M; Böhmer, D; Endres, S; Düwell, P; König, LM; Schnurr, M Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 2 Page Start: A7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P03.11 Exploring tumor-intrinsic factors regulating the recruitment of myeloid-derived suppressor cells (MDSC) in pancreatic ductal adenocarcinoma. (1st October 2020) Authors: Rambuscheck, C; Metzger, P; Hörth, C; Hennel, R; Bärthel, S; Falcomatà, C; Lauber, K; Endres, S; Saur, D; Schnurr, M; König, LM Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 2 Page Start: A26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P06.05 IDO1-deleted CAR T cells show improved therapeutic efficacy in murine pancreatic cancer models. (1st October 2020) Authors: Senz, AM; Metzger, P; Rubens, RK; Cadilha, B; Kirmaier, M; Lesch, S; Benmebarek, MR; Theurich, S; Murray, P; Endres, S; Kobold, S; König, LM; Duewell, P; Schnurr, M Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 2 Page Start: A43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P06.07 CXCR6 expression enhances accumulation of anti-mesothelin CAR T cells at the tumor site and their therapeutic efficacy in pancreatic cancer xenografts. (1st October 2020) Authors: Stoiber, S; Lesch, S; Ogonek, J; Cadilha, B; Benmebarek, M; Gottschlich, A; Metzger, P; Hörth, C; Nottebrock, A; Endres, S; Kobold, S Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 2 Page Start: A44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗